Skip to main content
Premium Trial:

Request an Annual Quote

MDL to Distribute Inpharmatica s Biopendium Database

NEW YORK, Feb. 24 (GenomeWeb News) - MDL Information Systems and Inpharmatica today said that MDL would serve as a non-exclusive distributor for Inpharmatica's Biopendium proteome annotation database.

Under the agreement, MDL, a wholly owned subsidiary of scientific publisher Elsevier with sales offices in 11 countries, will offer both installed and hosted versions of Biopendium worldwide, excluding Japan. Other terms of the agreement were not disclosed.

Inpharmatica said that the distribution agreement would allow it to devote more resources to building its drug discovery business.

Current subscribers to Biopendium include Pfizer, Aventis, Daiichi, Genentech, Serono, Riken, and UCB Pharma.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.